Pulmonary Fibrosis research hub

A Study Evaluating the Safety and Efficacy of Inhaled AP01 in Participants With Progressive Pulmonary Fibrosis

This study is testing a new inhaled medicine (AP01) for people with progressive pulmonary fibrosis. It aims to see if it's safe and effective, compared to a dummy medicine, over one year, alongside usual care.